Pancreatic Cancer

• CLINICAL_TRIALS trial_result · 2020-10-09
  Clinical Trial Update: The Safety and Efficacy of the Combination of Raltitrexed for Injection and Nab-Paclitaxel in Advanced Pancreatic Cancer [Phase 2]

  Phase 2 trial evaluating the safety and efficacy of raltitrexed for injection in combination with nab-paclitaxel for advanced pancreatic can…

• CLINICAL_TRIALS trial_result · 2020-10-01
  Clinical Trial Update: A Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]

  Phase II study of gimatecan (ST1481) in locally advanced or metastatic pancreatic cancer is ongoing with an unspecified status.

• CLINICAL_TRIALS trial_result · 2020-09-29
  Clinical Trial Update: FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]

  Phase 2 trial evaluating second-line treatment with FOLFIRI or modified FOLFIRI plus Veliparib in metastatic pancreatic cancer; results were…

• CLINICAL_TRIALS trial_result · 2020-09-18
  Clinical Trial Update: Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer [Phase 2]

  Phase 2 trial of gemcitabine and S-1 in locally advanced unresectable or metastatic pancreatic cancer has been terminated; results posted.

• CLINICAL_TRIALS trial_result · 2020-09-16
  Clinical Trial Update: Survivorship Promotion In Reducing IGF-1 Trial [Phase 2]

  Phase 2 trial evaluating survivorship promotion by reducing IGF-1 has completed, with results posted in 2020.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-09-09
  Clinical Trial Update: OMT-111 for Terminal Stage Solid Tumors [Phase 2]

  Phase 2 trial update for OMT-111 in terminal-stage solid tumors including breast and pancreatic cancer.

• CLINICAL_TRIALS trial_result · 2020-09-02
  Clinical Trial Update: Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma [Phase 2, Phase 3]

  A randomized multicenter Phase II/III trial comparing adjuvant gemcitabine to neoadjuvant/adjuvant FOLFIRINOX for resectable pancreatic carc…

• CLINICAL_TRIALS trial_result · 2020-08-31
  Clinical Trial Update: Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer [Phase 2]

  A Phase 2 study evaluating gemcitabine alone or with enzastaurin in advanced or metastatic pancreatic cancer has completed with results post…

• CLINICAL_TRIALS trial_result · 2020-08-31
  Clinical Trial Update: Pancreas Resection With and Without Drains [NA]

  Completed clinical trial comparing pancreas resection with and without drains; results posted in 2020.

• CLINICAL_TRIALS trial_result · 2020-08-10
  Clinical Trial Update: Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas [Phase 2]

  Phase 2 trial update on preoperative Folfirinox plus radiation therapy for resectable pancreatic adenocarcinoma; study completed with posted…

• CLINICAL_TRIALS trial_result · 2020-08-04
  Clinical Trial Update: Efficacy and Safety of Camrelizumab Combined With Nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer [Phase 2]

  Phase 2 trial assessing camrelizumab with nab-paclitaxel and gemcitabine for metastatic pancreatic cancer.

• CLINICAL_TRIALS trial_result · 2020-08-03
  Clinical Trial Update: Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma [Phase 2]

  Phase 2 trial evaluating pancreatic enzyme replacement after adjuvant chemotherapy in resected pancreatic adenocarcinoma was terminated; res…

• CLINICAL_TRIALS trial_result · 2020-07-31
  Clinical Trial Update: First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors [Phase 2]

  Phase 2 first-in-human study of GSK3145095 alone and in combination with other anticancer agents in adults with advanced solid tumors, termi…

• CLINICAL_TRIALS trial_result · 2020-07-20
  Clinical Trial Update: PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer [Phase 2]

  Phase 2 clinical trial comparing PEGPH20 plus nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine in untreated stage IV p…

• CLINICAL_TRIALS trial_result · 2020-07-17
  Clinical Trial Update: Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer [Phase 1, Phase 2]

  A Phase 1/2 clinical trial evaluating Tremelimumab and/or MEDI4736 (durvalumab) in combination with radiation therapy for unresectable pancr…

• CLINICAL_TRIALS trial_result · 2020-07-17
  Clinical Trial Update: Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer [NA]

  A completed clinical trial investigating the combination of SBRT with sequential S-1 for locally advanced pancreatic cancer with posted resu…

• CLINICAL_TRIALS trial_result · 2020-07-16
  Clinical Trial Update: Ibrutinib Combined With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]

  Phase 1/2 trial evaluating ibritinib in combination with gemcitabine and nab-paclitaxel for metastatic pancreatic adenocarcinoma; study comp…

• CLINICAL_TRIALS trial_result · 2020-07-08
  Clinical Trial Update: Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer [Phase 1, Phase 2]

  Clinical trial update for Olaptesed (NOX-A12) alone and with pembrolizumab in metastatic colorectal and pancreatic cancer has completed Phas…

• CLINICAL_TRIALS trial_result · 2020-06-26
  Clinical Trial Update: Influence of Local Anesthetic Administration on the Cancer Recurrence Rate After Pancreatic Oncologic Surgery [Phase 2]

  Phase 2 clinical trial evaluating whether local anesthetic administration influences cancer recurrence after pancreatic oncologic surgery.

• CLINICAL_TRIALS trial_result · 2020-06-04
  Clinical Trial Update: The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic Carcinoma [Phase 2]

  Phase 2 clinical trial evaluating camrelizumab plus apatinib as second-line therapy for advanced pancreatic cancer.

• CLINICAL_TRIALS trial_result · 2020-06-01
  Clinical Trial Update: Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer [Phase 1, Phase 2]

  Clinical trial update on the safety and efficacy of AMG 820 plus pembrolizumab in select advanced solid tumors (Phase 1/2; completed).

• CLINICAL_TRIALS trial_result · 2020-05-28
  Clinical Trial Update: Vaccine Treatment for Surgically Resected Pancreatic Cancer [Phase 1, Phase 2]

  A Phase 1/2 clinical trial update for a vaccine treatment in patients with surgically resected pancreatic cancer has completed.

• CLINICAL_TRIALS trial_result · 2020-05-28
  Clinical Trial Update: Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer [Phase 3]

  Phase 3 trial in borderline resectable or locally advanced unresectable pancreatic cancer was terminated.

• CLINICAL_TRIALS trial_result · 2020-05-28
  Clinical Trial Update: Immunotherapy Study for Surgically Resected Pancreatic Cancer [Phase 3]

  Phase 3 trial update for an immunotherapy approach in surgically resected pancreatic cancer.

• CLINICAL_TRIALS trial_result · 2020-05-28
  Clinical Trial Update: Vaccine Study for Surgically Resected Pancreatic Cancer [Phase 2]

  Phase 2 clinical trial update for a vaccine study in patients with surgically resected pancreatic cancer has completed.